newsfilter
← Latest News
Business Wire·

Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma

Focus on expansion in nephrology, and to maximize opportunities on the iron portfolio Vifor Pharma to divest non-core assets on finished drug product facilities to CordenPharma, reducing organizational complexity, and optimizing cost structure